Cargando…
Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity
A thorough analysis of the thermodynamic stability of various complexes of aminoguanidine (AG) with Fe(III) at a physiological pH is presented. Moreover, the secondary antioxidant activity of AG is studied with respect to its kinetic role in the Fe(III) reduction to Fe(II) when reacting with the sup...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463863/ https://www.ncbi.nlm.nih.gov/pubmed/32824195 http://dx.doi.org/10.3390/antiox9080756 |
_version_ | 1783577231984951296 |
---|---|
author | García-Díez, Guillermo Mora-Diez, Nelaine |
author_facet | García-Díez, Guillermo Mora-Diez, Nelaine |
author_sort | García-Díez, Guillermo |
collection | PubMed |
description | A thorough analysis of the thermodynamic stability of various complexes of aminoguanidine (AG) with Fe(III) at a physiological pH is presented. Moreover, the secondary antioxidant activity of AG is studied with respect to its kinetic role in the Fe(III) reduction to Fe(II) when reacting with the superoxide radical anion or ascorbate. Calculations are performed at the M05(SMD)/6-311+G(d,p) level of theory. Solvent effects (water) are taken into account in both geometry optimizations and frequency calculations employing the SMD solvation method. Even though the results of this study show that AG can form an extensive number of stable complexes with Fe(III), none of these can reduce the rate constant of the initial step of the Haber–Weiss cycle when the reducing agent is [Formula: see text]. However, when the reductant is the ascorbate anion, AG is capable of reducing the rate constant of this reaction significantly, to the point of inhibiting the production of (•)OH radicals. In fact, the most stable complex of Fe(III) with AG, having a [Formula: see text] of −37.9 kcal/mol, can reduce the rate constant of this reaction by 7.9 × 10(5) times. Thus, AG possesses secondary antioxidant activity relative to the Fe(III)/Fe(II) reduction with ascorbate, but not with [Formula: see text]. Similar results have also been found for AG relative to the Cu(II)/Cu(I) reduction, in agreement with experimental results. |
format | Online Article Text |
id | pubmed-7463863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74638632020-09-04 Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity García-Díez, Guillermo Mora-Diez, Nelaine Antioxidants (Basel) Article A thorough analysis of the thermodynamic stability of various complexes of aminoguanidine (AG) with Fe(III) at a physiological pH is presented. Moreover, the secondary antioxidant activity of AG is studied with respect to its kinetic role in the Fe(III) reduction to Fe(II) when reacting with the superoxide radical anion or ascorbate. Calculations are performed at the M05(SMD)/6-311+G(d,p) level of theory. Solvent effects (water) are taken into account in both geometry optimizations and frequency calculations employing the SMD solvation method. Even though the results of this study show that AG can form an extensive number of stable complexes with Fe(III), none of these can reduce the rate constant of the initial step of the Haber–Weiss cycle when the reducing agent is [Formula: see text]. However, when the reductant is the ascorbate anion, AG is capable of reducing the rate constant of this reaction significantly, to the point of inhibiting the production of (•)OH radicals. In fact, the most stable complex of Fe(III) with AG, having a [Formula: see text] of −37.9 kcal/mol, can reduce the rate constant of this reaction by 7.9 × 10(5) times. Thus, AG possesses secondary antioxidant activity relative to the Fe(III)/Fe(II) reduction with ascorbate, but not with [Formula: see text]. Similar results have also been found for AG relative to the Cu(II)/Cu(I) reduction, in agreement with experimental results. MDPI 2020-08-15 /pmc/articles/PMC7463863/ /pubmed/32824195 http://dx.doi.org/10.3390/antiox9080756 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-Díez, Guillermo Mora-Diez, Nelaine Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title | Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title_full | Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title_fullStr | Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title_full_unstemmed | Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title_short | Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity |
title_sort | theoretical study of the iron complexes with aminoguanidine: investigating secondary antioxidant activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463863/ https://www.ncbi.nlm.nih.gov/pubmed/32824195 http://dx.doi.org/10.3390/antiox9080756 |
work_keys_str_mv | AT garciadiezguillermo theoreticalstudyoftheironcomplexeswithaminoguanidineinvestigatingsecondaryantioxidantactivity AT moradieznelaine theoreticalstudyoftheironcomplexeswithaminoguanidineinvestigatingsecondaryantioxidantactivity |